Impaired Lymphocyte Responses and Their Restoration in Oral Cancer Patients Expressing Distinct TCR Variable Region

REFERENCES

• Underwood J. C. Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br. J. Cancer 1974; 30: 538–548
   PubMed Web of Science ®Google Scholar
• Hellstrom I., Ledbetter J. A., Scholler N., Yang Y., Ye Z., Goodman G., Pullman J., Hayden-Ledbetter M., Hellstrom K. E. CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer. Proc. Natl. Acad Sci. U S A 2001; 98: 6783–6788
   PubMed Web of Science ®Google Scholar
• Zea A. H., Curti B. D., Longo D. L., Alvord W. G., Strobl S. L., Mizoguchi H., Creekmore S. P., O'Shea J. J., Power G. C., Urba W. J. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res. 1995; 1(11)1327–1335
   PubMed Web of Science ®Google Scholar
• Garcia K. C., Teyton L., Wilson I. A. Structural basis of T cell recognition. Annu. Rev. Immunol. 1999; 17: 369–397
   PubMed Web of Science ®Google Scholar
• Kronenberg M., Siu G., Hood L. E., Shastri N. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu. Rev. Immunol. 1986; 4: 529–591
   PubMed Web of Science ®Google Scholar
• Pannetier C., Even J., Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16(4)176–181
   PubMedGoogle Scholar
• Sensi M., Parmiani G. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol Today 1995; 16(12)588–595
   PubMedGoogle Scholar
• Laad A. D., Thomas M. L., Fakih A. R., Chiplunkar S V. Human gamma delta T cells recognize heat shock protein-60 on oral tumor cells. Int. J. Cancer. 1999; 80(5)709–714
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162(1)156–159
   PubMed Web of Science ®Google Scholar
• Monteiro J., Hingorani R., Choi I. H., Silver J., Pergolizzi R., Gregersen P. K. Oligoclonality in the human CD8+ T cell repertoire in normal subjects and monozygotic twins: implications for studies of infectious and autoimmune diseases. Mol Med. 1995; 1(6)614–24
   PubMed Web of Science ®Google Scholar
• Kode J., Advani S., Chiplunkar S. T-cell receptor gamma and delta gene rearrangements in T-cell acute lymphoblastic leukemia in Indian patients. Leuk Lymphoma 2000; 36(3–4)331–338
   PubMed Web of Science ®Google Scholar
• Maccalli C., Pisarra P., Vegetti C., Sensi M., Parmiani G., Anichini A. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions. J. Immunol. 1999; 163(12)6912–6923
   PubMed Web of Science ®Google Scholar
• Maccalli C., Farina C., Sensi M., Parmiani G., Anichini A. TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patients. J. Immunol. 1997; 158(12)5902–5913
   PubMed Web of Science ®Google Scholar
• Whiteside T. L. Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?. Cancer Immunol Immunother 2004; 53(10)865–878
   PubMed Web of Science ®Google Scholar
• thor Straten P., Guldberg P., Gronbaek K., Hansen M. R., Kirkin A. F., Seremet T., Zeuthen J., Becker J. C. In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes. J. Immunol. 1999; 163(1)443–447
   PubMed Web of Science ®Google Scholar
• Fitzgerald J. E., Ricalton N. S., Meyer A. C., West S. G., Kaplan H., Behrendt C., Kotzin B. L. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J. Immunol. 1995; 154(7)3538–3547
   PubMed Web of Science ®Google Scholar
• Akolkar P. N., Gulwani-Akolkar B., Pergolizzi R., Bigler R. D., Silver J. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J. Immunol. 1993; 150(7)2761–2773
   PubMed Web of Science ®Google Scholar
• Benoist C., Mathis D. Positive selection of the T cell repertoire: where and when does it occur?. Cell 1989; 58(6)1027–1033
   PubMed Web of Science ®Google Scholar
• Grunewald J., Janson C. H., Wigzell H. Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes. Eur. J. Immunol. 1991; 21(3)819–822
   PubMed Web of Science ®Google Scholar
• Davey M. P., Meyer M. M., Munkirs D. D., Babcock D., Braun M. P., Hayden J. B., Antocy C. T-cell receptor variable beta genes show differential expression in CD4 and CD8 T cells. Hum. Immunol. 1991; 32(3)194–202
   PubMed Web of Science ®Google Scholar
• Maini M. K., Casorati G., Dellabona P., Wack A., Beverley P. C. T-cell clonality in immune responses. Immunol. Today. 1999; 20(6)262–266
   PubMedGoogle Scholar
• Saito T., Kuss I., Dworacki G., Gooding W., Johnson J. T., Whiteside T. L. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin. Cancer Res. 1999; 5(6)1263–1273
   PubMed Web of Science ®Google Scholar
• Dworacki G., Meidenbauer N., Kuss I., Hoffmann T. K., Gooding W., Lotze M., Whiteside T. L. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Clin. Cancer Res. 2001; 7(3 Suppl)947s–957s
   PubMed Web of Science ®Google Scholar
• Hoffmann T. K., Dworacki G., Tsukihiro T., Meidenbauer N., Gooding W., Johnson J. T., Whiteside T. L. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin. Cancer Res. 2002; 8(8)2553–2562
   PubMed Web of Science ®Google Scholar
• Kuss I., Donnenberg A. D., Gooding W., Whiteside T. L. Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck. Br. J. Cancer. 2003; 88(2)223–30
   PubMed Web of Science ®Google Scholar
• Whiteside T. L. Immunobiology of head and neck cancer. Cancer Metastasis Rev. 2005; 24(1)95–105
   PubMed Web of Science ®Google Scholar
• Renner C., Ohnesorge S., Held G., Bauer S., Jung W., Pfitzenmeier J. P., Pfreundschuh M. T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood. 1996; 88(1)236–241
   PubMed Web of Science ®Google Scholar
• Farace F., Angevin E., Vanderplancke J., Escudier B., Triebel F. The decreased expression of CD3 zeta chains in cancer patients is not reversed by IL-2 administration. Int. J. Cancer. 1994; 59(6)752–755
   PubMed Web of Science ®Google Scholar
• Guarini A., Riera L., Cignetti A., Montacchini L., Massaia M., Foa R. Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules. Blood. 1997; 89(1)212–218
   PubMed Web of Science ®Google Scholar